We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Secures Option to Invest Additional $22 Million in Israeli Company
Teva Secures Option to Invest Additional $22 Million in Israeli Company
June 12, 2006
Israel-based drugmaker CureTech has finalized an agreement in which Teva Pharmaceutical has received an option to invest $22 million in the company, in addition to a $6 million investment announced several months ago.